Oxford BioMedica plc (GB:OXB)
LSE:OXB
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 168.74M | £ 128.80M | £ 89.54M | £ 139.99M | £ 142.80M |
| Gross Profit | £ 65.98M | £ 53.02M | £ 39.73M | £ 69.18M | £ 82.64M |
| Operating Income | £ -33.54M | £ -39.38M | £ -184.17M | £ -30.22M | £ 20.77M |
| EBITDA | £ -33.54M | £ -14.33M | £ -148.62M | £ -10.80M | £ 33.22M |
| Net Income | £ -30.13M | £ -43.19M | £ -157.49M | £ -39.16M | £ 19.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 96.88M | £ 60.65M | £ 103.72M | £ 141.31M | £ 109.02M |
| Total Assets | £ 325.72M | £ 231.64M | £ 252.34M | £ 460.18M | £ 237.23M |
| Total Debt | £ 106.64M | £ 108.76M | £ 111.46M | £ 114.28M | £ 9.34M |
| Net Debt | £ 9.76M | £ 48.11M | £ 7.74M | £ -27.00M | £ -99.60M |
| Total Liabilities | £ 234.37M | £ 171.16M | £ 174.51M | £ 223.99M | £ 49.89M |
| Stockholders' Equity | £ 91.35M | £ 57.05M | £ 74.01M | £ 204.65M | £ 187.34M |
| Cash Flow | |||||
| Free Cash Flow | £ -10.21M | £ -58.12M | £ -38.35M | £ -28.91M | £ 15.99M |
| Operating Cash Flow | £ -5.45M | £ -50.63M | £ -28.52M | £ -12.62M | £ 25.45M |
| Investing Cash Flow | £ -8.10M | £ 5.63M | £ 2.81M | £ -56.46M | £ -9.46M |
| Financing Cash Flow | £ 50.59M | £ 2.91M | £ -12.70M | £ 98.62M | £ 46.21M |